These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23449418)

  • 21. Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Abu Lila AS; Moriyoshi N; Fukushima M; Huang CL; Wada H; Ishida T
    Cancer Lett; 2017 Aug; 400():223-231. PubMed ID: 27838412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
    Yao Y; Su Z; Liang Y; Zhang N
    Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
    Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
    J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice.
    Hashimoto Y; Abu Lila AS; Shimizu T; Ishida T; Kiwada H
    J Control Release; 2014 Jun; 184():1-8. PubMed ID: 24727075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
    Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
    Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules.
    Alaaeldin E; Abu Lila AS; Ando H; Fukushima M; Huang CL; Wada H; Sarhan HA; Khaled KA; Ishida T
    J Control Release; 2017 Jun; 255():210-217. PubMed ID: 28461099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy].
    Ishida O; Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):657-62. PubMed ID: 9549352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
    Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles.
    Pittella F; Cabral H; Maeda Y; Mi P; Watanabe S; Takemoto H; Kim HJ; Nishiyama N; Miyata K; Kataoka K
    J Control Release; 2014 Mar; 178():18-24. PubMed ID: 24440662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.